GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Akdital (CAS:AKT) » Definitions » GF Value

Akdital (CAS:AKT) GF Value : MAD0.00 (As of Jun. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Akdital GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-06-12), Akdital's share price is MAD671.00. Akdital's GF Value is MAD0.00. Therefore, Akdital's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Akdital is Not Valued.


Akdital  (CAS:AKT) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Akdital's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=671.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akdital GF Value Related Terms

Thank you for viewing the detailed overview of Akdital's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Akdital (CAS:AKT) Business Description

Traded in Other Exchanges
N/A
Address
258 Route de l’Oasis, Casablanca, MAR, 20250
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, neurosurgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.

Akdital (CAS:AKT) Headlines

From GuruFocus

Everspan Group Announces Retirement of Wyatt Blackburn

By Business Wire Business Wire 11-29-2022

Penny Parisoff Partners With Ambac to Create Human Services-Focused MGA

By Business Wire Business Wire 06-30-2022

Xchange Benefits to host Experience Xchange educational symposium

By Business Wire Business Wire 05-25-2023

Ambac to Release Second Quarter 2022 Results on August 8, 2022

By Business Wire Business Wire 07-26-2022

Ambac Settles RMBS Litigation Against Nomura

By Business Wire Business Wire 01-03-2023

Ambac Reports Second Quarter 2023 Results

By Business Wire 08-07-2023

Ambac to Release Fourth Quarter 2022 Results on February 28, 2023

By Business Wire Business Wire 02-14-2023